The transformative potential of digital therapeutics in pediatrics.
Where this comes from
- Record sourced from PubMed, PMID 41086343.
- Also identified by DOI 10.1097/j.pain.0000000000003713.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Digital therapeutics (DTx) are applied healthcare technologies designed to prevent, manage, or treat health conditions. In pediatric pain, DTx can enhance access to evidence-based, effective pain assessment and management. This article explores technologies such as artificial intelligence (AI), extended reality (XR), mobile health (mHealth), and sensors (eg, smartwatches). Equitable DTx deployment can address geographic disparities by enabling on-demand pain care, necessitating an intelligent learning DTx-enabled health system. Ensuring safety will require comprehensive regulatory frameworks at national and international levels. Achieving this transformation requires robust regulatory frameworks, workforce training, and equitable codesign to ensure accessible, evidence-based care for all pediatric populations.
Medical subject headings
- Pediatrics
- Pain Management
- Digital Health